|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 07-30 | Pfizer to Proceed With Regulatory Filings for Litfulo in Nonsegmental Vitiligo | MT |
| 07-30 | Bristol Myers raises 2026 forecast as Eliquis, newer medicines power results | RE |
| Market Cap | 143B 124B 115B 106B 200B 13,607B 203B 1,360B 534B 6,774B 535B 524B 22,715B | P/E 2026 * |
12.7x | P/E 2027 * | 13.1x |
|---|---|---|---|---|---|
| Enterprise Value | 192B 167B 155B 143B 269B 18,319B 273B 1,830B 718B 9,120B 721B 705B 30,582B | EV / Sales 2026 * |
3.11x | EV / Sales 2027 * | 3.13x |
| Free-Float |
59.05% | Yield 2026 * |
6.88% | Yield 2027 * | 6.95% |
Last Transcript: Pfizer Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 01/01/2019 |
David Denton
DFI | Director of Finance/CFO | 60 | 02/05/2022 |
| Chief Tech/Sci/R&D Officer | - | 01/01/2007 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 01/09/2007 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 27/09/2013 |
Albert Bourla
CHM | Chairman | 64 | 01/01/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.53% | -3.95% | +50.70% | +153.56% | 1,024B | |
| +0.21% | -2.68% | +53.20% | +51.79% | 618B | |
| -2.51% | -3.25% | +28.54% | +68.94% | 443B | |
| +0.06% | -0.42% | +37.53% | +30.67% | 349B | |
| -0.69% | -0.30% | +13.76% | +12.83% | 264B | |
| -7.37% | -4.40% | -0.74% | -44.28% | 209B | |
| -0.64% | +2.43% | +29.74% | +65.93% | 208B | |
| -0.82% | +0.70% | +15.05% | +72.05% | 162B | |
| +0.69% | +5.19% | +47.66% | +6.14% | 133B | |
| Average | -1.29% | -0.59% | +30.60% | +46.40% | 378.86B | |
| Weighted average by Cap. | -1.00% | -1.80% | +37.83% | +73.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 61.74B 53.67B 49.96B 45.87B 86.62B 5,894B 87.96B 589B 231B 2,934B 232B 227B 9,839B | 59.37B 51.61B 48.04B 44.1B 83.28B 5,667B 84.57B 566B 222B 2,821B 223B 218B 9,460B |
| Net income | 10.63B 9.24B 8.6B 7.9B 14.92B 1,015B 15.15B 101B 39.8B 505B 39.93B 39.06B 1,694B | 10.28B 8.94B 8.32B 7.64B 14.42B 981B 14.64B 98.04B 38.48B 489B 38.61B 37.76B 1,638B |
| Net Debt | 49.36B 42.91B 39.94B 36.67B 69.25B 4,712B 70.32B 471B 185B 2,346B 185B 181B 7,866B | 43.17B 37.52B 34.93B 32.07B 60.56B 4,121B 61.49B 412B 162B 2,051B 162B 159B 6,879B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
